FdaApplication
NDA 214410
Identifiers
- fda_app_no: NDA214410
Properties
| Property | Value |
|---|---|
| applicant_name | GENENTECH INC |
| application_type | NDA |
| approval_date | 2020-11-23 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XOFLUZA | BALOXAVIR MARBOXIL | 2MG/ML | FOR SUSPENSION;ORAL |
| XOFLUZA | BALOXAVIR MARBOXIL | 30MG/PACKET | FOR SUSPENSION;ORAL |
| XOFLUZA | BALOXAVIR MARBOXIL | 40MG/PACKET | FOR SUSPENSION;ORAL |
3 products